Total compensation includes information disclosed in company proxy statements, including base salary, bonus, stock awards and option awards, as well as other benefits and perks.
1. Albert Bourla, PhD, Pfizer (New York City) — $30.54 million
2. Christopher Viehbacher, Biogen (Cambridge, Mass.) — $30.49 million
3. Ari Bousbib, IQVIA Holdings (Durham, N.C.) — $29.71 million
4. Marc Casper, Thermo Fisher Scientific (Waltham, Mass.) — $28.21 million
5. Franis deSouza, Illumina (San Diego) — $26.75 million *Mr. deSouza left the CEO position June 11.
